Distribution of the Major Cytochrome P450 (CYP) 2C9 Genetic Variants in a Saudi Population

被引:12
|
作者
Mirghani, Rajaa A. [1 ]
Chowdhary, Gulnaz [1 ]
Elghazali, Gehad [1 ,2 ,3 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Fac Med, King Fahad Med City, Riyadh 11393, Saudi Arabia
[2] King Fahad Med City, Dept Immunol, Riyadh, Saudi Arabia
[3] Univ Shendi, Fac Med & Hlth Sci, Shendi, Sudan
关键词
MUTANT ALLELES; P4502C9; POLYMORPHISMS; CYP2C19; PHARMACOKINETICS; FREQUENCIES; OXIDATION; GENOTYPES; LOSARTAN; WARFARIN;
D O I
10.1111/j.1742-7843.2011.00692.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (CYP) 2C9 is responsible for the metabolism of a number of widely used drugs such as oral anticoagulants, oral antidiabetics and non-steroidal anti-inflammatory drugs. The CYP2C9 is a genetically polymorphic enzyme. The most common allele is CYP2C9*1, while CYP2C9*2 and CYP2C9*3 are the less-frequent variants. The activity of the enzyme encoded by either CYP2C9 *2 or *3 variant is lower compared with that of the CYP2C9*1. The metabolism of most of the CYP2C9 substrates decreases in varying degrees in subjects carrying the CYP2C9 *2 or *3 allele. The aim of this study was to investigate the frequencies of the major variants of the CYP2C9 in Saudi Arabians.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 50 条
  • [11] Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450CYP2C9 on sensitivity to acenocournarol
    Hermida, J
    Zarza, J
    Alberca, I
    Montes, R
    López, ML
    Molina, E
    Rocha, E
    BLOOD, 2002, 99 (11) : 4237 - 4239
  • [12] Modeling complexes of substrates with cytochrome P450 2C9
    A. A. Pogrebnoi
    M. A. Grishina
    V. A. Potemkin
    D. A. Sysakov
    Pharmaceutical Chemistry Journal, 2010, 44 : 237 - 240
  • [13] Cytochrome P450 2C9 Is a Target for Photoreceptor Neuroprotection
    Chang, Qing
    Chen, Siquan
    Joseph, Bogaard
    Cao, Dingcai
    Grassi, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [14] MODELING COMPLEXES OF SUBSTRATES WITH CYTOCHROME P450 2C9
    Pogrebnoi, A. A.
    Grishina, M. A.
    Potemkin, V. A.
    Sysakov, D. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2010, 44 (05) : 237 - 240
  • [15] The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin
    Tabrizi, AR
    Zehnbauer, BA
    Borecki, IB
    McGrath, SD
    Buchman, TG
    Freeman, BD
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (03) : 267 - 273
  • [16] Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic DrugsClinical Relevance
    Julia Kirchheiner
    Ivar Roots
    Mark Goldammer
    Bernd Rosenkranz
    Jürgen Brockmöller
    Clinical Pharmacokinetics, 2005, 44 : 1209 - 1225
  • [17] Cytochrome P450 2C9-CYP2C9
    Van Booven, Derek
    Marsh, Sharon
    McLeod, Howard
    Carrillo, Michelle Whirl
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (04): : 277 - 281
  • [18] Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma
    Chan, Andrew T.
    Zauber, Ann G.
    Hsu, Meier
    Breazna, Aurora
    Hunter, David J.
    Rosenstein, Rebecca B.
    Eagle, Craig J.
    Hawk, Ernest T.
    Bertagnolli, Monica M.
    GASTROENTEROLOGY, 2009, 136 (07) : 2127 - 2136
  • [19] Metabolism of 7-ethoxycoumarin, flavanone and steroids by cytochrome P450 2C9 variants
    Uno, Tomohide
    Nakano, Ryosuke
    Kanamaru, Kengo
    Takenaka, Shinji
    Uno, Yuichi
    Imaishi, Hiromasa
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (08) : 486 - 493
  • [20] Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations
    Cho, Myung-A
    Yoon, Jihoon G.
    Kim, Vitchan
    Kim, Harim
    Lee, Rowoon
    Lee, Min Goo
    Kim, Donghak
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (06) : 577 - 583